Biotech IPOs; don't let the numbers deceive
Biotech IPOs; don’t let the numbers deceive
Take the biotechnology industry, which in 2003 raised $16.7 billion in capital — its second-best year ever. Yet, many of the biotech companies that went public in the last quarter of the year were miserable after-market performers.
Comments are closed.